China's L-Arginine market weakened significantly throughout June as abundant domestic supply and sluggish downstream demand continued to pressure prices. Producers maintained high operating rates, while stable feedstock and electricity costs supported elevated L-Arginine output. Capacity expansions by major manufacturers further increased availability, leading to higher inventories and intensified competition among suppliers. Demand for L-Arginine remained soft across nutraceutical, pharmaceutical, and animal feed industries, with buyers purchasing only for immediate needs while delaying bulk procurement in anticipation of lower prices. Looking ahead, the L-Arginine market is expected to remain under pressure due to ample supply, comfortable inventories, and weak spot demand. However, stronger export inquiries or production curtailments could help stabilize L-Arginine prices in the coming weeks.
Selenis has effectively manufactured recycled PET chips using terephthalic acid sourced from Circ®, a textile-to-textile recycler based in Virginia. The chip production took place through a series of batches at Selenis' pilot plant in San-Giorgio, Italy. By utilizing inputs recovered from polycotton textile waste, Selenis has created high-quality PET chip, which has been further processed into DTY yarn. This yarn will play a crucial role in product development as Circ prepares for additional capsule launches. Selenis is leveraging the success of this initial collaboration phase and is committed to advancing towards an offtake partnership to support Circ's inaugural industrial facility.
Eduardo Santos, Head of Corporate Strategy at Selenis, remarked that the monomer synthesis showed a performance comparable to virgin terephthalic acid. He expressed optimism about the consistent quality of Circ's monomer output and anticipated future commercial success. Santos pointed out that the Circ partnership complements Selenis's existing mission and goals for a more sustainable textile industry. He further stated their anticipation of expanding upon this collaboration and providing support for Circ's forthcoming commercial production trials.
